Company logo

AVGR - Avinger, Inc.

NASDAQ -> Healthcare -> Medical Devices
Redwood City, United States

AVGR price evolution
AVGR
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $23.08 $26.7 $30.45 $22.18
Short term investments
Net receivables $1.4 $1.79 $1.53 $1.48
Inventory $4.52 $4.12 $3.94 $3.88
Total current assets $29.66 $33.72 $37.23 $27.89
Long term investments
Property, plant & equipment $3.62 $3.98 $4.4 $4.79
Goodwill & intangible assets
Total noncurrent assets $4.07 $4.47 $4.88 $5.3
Total investments
Total assets $33.74 $38.19 $42.11 $33.2
Current liabilities
Accounts payable $1.18 $1.04 $0.79 $0.69
Deferred revenue
Short long term debt $2.07 $3.59
Total current liabilities $7.44 $6.49 $7.24 $7.46
Long term debt $11.85 $11.43 $11.32 $9.4
Total noncurrent liabilities $14.73 $14.42 $14.4 $12.66
Total debt $11.85 $11.43 $13.39 $12.99
Total liabilities $22.17 $20.91 $21.63 $20.12
Shareholders' equity
Retained earnings -$379.76 -$374.85 -$372.39 -$367.34
Other shareholder equity
Total shareholder equity $11.57 $17.28 $20.48 $13.08
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Current assets
Cash $22.18 $10.94 $16.41 $5.39
Short term investments
Net receivables $1.48 $1.46 $1.15 $1.13
Inventory $3.88 $3.91 $3.42 $4.29
Total current assets $27.89 $16.62 $21.62 $11.45
Long term investments
Property, plant & equipment $4.79 $6.52 $2.08 $2.95
Goodwill & intangible assets
Total noncurrent assets $5.3 $7.2 $2.08 $3.64
Total investments
Total assets $33.2 $23.82 $23.7 $15.09
Current liabilities
Accounts payable $0.69 $0.66 $1.15 $1.27
Deferred revenue
Short long term debt $3.59 $8.97 $7.49 $44.74
Total current liabilities $7.46 $12.79 $14.2 $50.48
Long term debt $9.4
Total noncurrent liabilities $12.66 $4.14 $0.04 $0.3
Total debt $12.99 $8.97 $7.49 $44.74
Total liabilities $20.12 $16.93 $14.24 $50.78
Shareholders' equity
Retained earnings -$367.34 -$348.33 -$328.88 -$301.33
Other shareholder equity
Total shareholder equity $13.08 $6.89 $9.46 -$35.69
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue $2.37 $2.8 $2.56 $2.73
Cost of revenue $1.57 $1.78 $1.67 $1.75
Gross Profit $0.8 $1.02 $0.89 $0.98
Operating activities
Research & development $1.4 $1.51 $1.6 $1.39
Selling, general & administrative $3.89 $3.92 $3.94 $3.83
Total operating expenses $5.29 $5.42 $5.54 $5.21
Operating income -$4.49 -$4.41 -$4.65 -$4.23
Income from continuing operations
EBIT -$4.49 -$2.05 -$4.65 -$4.18
Income tax expense
Interest expense $0.42 $0.4 $0.4 $0.45
Net income
Net income -$4.91 -$2.45 -$5.05 -$4.63
Income (for common shares) -$5.96 -$3.5 -$6.1 -$5.59
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Revenue
Total revenue $8.76 $9.13 $7.92 $9.93
Cost of revenue $6.14 $6.26 $6.53 $13
Gross Profit $2.62 $2.87 $1.38 -$3.07
Operating activities
Research & development $5.7 $5.69 $6.01 $11.32
Selling, general & administrative $14.33 $16.53 $17.44 $25.12
Total operating expenses $20.02 $22.23 $23.45 $39.48
Operating income -$17.4 -$19.36 -$22.07 -$42.55
Income from continuing operations
EBIT -$17.31 -$17.97 -$21.87 -$42.43
Income tax expense
Interest expense $1.69 $1.48 $5.69 $6.3
Net income
Net income -$19.01 -$19.45 -$27.56 -$48.73
Income (for common shares) -$22.87 -$23.03 -$35.69 -$48.73
(in millions $) 30 Sep 2021 30 Jun 2021 31 Mar 2021 31 Dec 2020
Net income -$4.91 -$2.45 -$5.05 -$4.63
Operating activities
Depreciation $0.16 $0.17 $0.19 $0.22
Business acquisitions & disposals
Stock-based compensation $0.24 $0.3 $0.42 $0.35
Total cash flows from operations -$3.62 -$3.74 -$4.8 -$3.16
Investing activities
Capital expenditures -$0.01 -$0.01 $0.03
Investments
Total cash flows from investing -$0.01 -$0.01 $0.03
Financing activities
Dividends paid
Sale and purchase of stock $13.08 -$0
Net borrowings
Total cash flows from financing $13.08 $13.08 -$0
Effect of exchange rate
Change in cash and equivalents -$3.62 -$3.75 $8.26 -$3.14
(in millions $) 31 Dec 2020 31 Dec 2019 31 Dec 2018 31 Dec 2017
Net income -$19.01 -$19.45 -$27.56 -$48.73
Operating activities
Depreciation $0.9 $0.89 $1.28 $1.48
Business acquisitions & disposals
Stock-based compensation $1.51 $2.09 $3.19 $4.97
Total cash flows from operations -$14.84 -$17.26 -$18.47 -$34.48
Investing activities
Capital expenditures $0.07 -$0.07 -$0 -$0.04
Investments
Total cash flows from investing $0.07 -$0.07 -$0 -$0.04
Financing activities
Dividends paid
Sale and purchase of stock $23.68 $11.87 $14.12 $3.83
Net borrowings $2.33 -$0.15 -$0.03
Total cash flows from financing $26.01 $11.87 $29.49 $3.81
Effect of exchange rate
Change in cash and equivalents $11.24 -$5.47 $11.02 -$30.71
Fundamentals
Market cap $28.19M
Enterprise value $16.97M
Shares outstanding 95.56M
Revenue $10.46M
EBITDA -$14.64M
EBIT -$15.38M
Net Income -$17.05M
Revenue Q/Q 2.78%
Revenue Y/Y 21.74%
P/E ratio -1.65
EV/Sales 1.62
EV/EBITDA -1.16
EV/EBIT -1.10
P/S ratio 2.70
P/B ratio 2.44
Book/Share 0.12
Cash/Share 0.24
EPS -$0.18
ROA -46.31%
ROE -109.27%
Debt/Equity 1.54
Net debt/EBITDA 0.06
Current ratio 3.99
Quick ratio 3.38